News | December 16, 2010

Balloon Catheter System for Coronary Revascularization Receives CE Mark

December 16, 2010 – A system designed to improve acute coronary syndrome (ACS) revascularization following percutaneous coronary intervention (PCI) has received CE Mark. The PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System, by Miracor Medical Systems can be used during coronary revascularization procedures to intermittently increase the pressure in the coronary venous system.

The catheter incorporates a soft distal atraumatic tip and can be placed from the femoral or jugular vein using a standard coronary sinus sheath or over the wire into the coronary sinus. Two marker bands will clearly show the extension of the balloon in the coronary sinus. The low profile balloon is automatically inflated and deflated based on the measurement of the coronary sinus pressure and the patient ECG.

The catheter is maintained in the coronary sinus using an outer hypotube that is laser cut to provide gradual flexibility for easy access into the coronary sinus. The catheter is connected to the console through two pneumatic tubes in which helium is shuttled to and from the balloon. In addition, the coronary sinus pressure is monitored through the center lumen of the catheter.

"Nearly one in three heart attack patients has troublesome microcirculatory blood flow even after coronary angioplasty, which increases the risk of death within a year by almost 300 percent,” said Jon H. Hoem, CEO of Miracor. “PICSO is designed to benefit these patients."

In 2011, the company will initiate the post CE-Mark RAMSES clinical trial in seven European centers. Professor Jan Piek, Academic Medical Center, Amsterdam, will be the principal investigator.

"As we have seen in the 'Prepare PICSO' study, the Miracor technology reduces ischemia in acute coronary syndrome patients," Piek said. "We believe that the technology can open a completely new way to treat critically ill acute coronary syndrome patients."

For more information: www.miracormedical.com

Related Content

Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Lutonix 035 Drug Coated Balloon Earns Additional FDA Premarket Approval
Technology | Drug-Eluting Balloons| August 29, 2017
C.R. Bard Inc. announced the Lutonix 035 Drug Coated Balloon PTA Catheter (DCB) has been granted premarket approval (...
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
Spectranetics Announces FDA Approval of Stellarex Drug-Coated Balloon
Technology | Drug-Eluting Balloons| July 26, 2017
The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market approval (PMA) of the...
News | June 12, 2017
June 12, 2017 – Med Alliance announced completion on schedule of patient enrollment in the first-in-man (FIM) study o
Abbott recalls its NC Balloon catheters
News | Balloon Catheter| May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Sponsored Content | Videos | EP Lab| May 17, 2017
This video, provided by Spectranetics, demonstrates how to deploy the Bridge Occlusion Balloon used to seal accidenta
Contego Medical Receives CE Mark for Vanguard IEP Peripheral Balloon Angioplasty System
News | Peripheral Artery Disease (PAD)| May 17, 2017
Contego Medical LLC announced recently that it has received CE Marking of its Vanguard IEP Peripheral Balloon...
Overlay Init